Literature DB >> 16861545

Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome.

Harald Brodoefel1, Monika Vogel, Holger Hebart, Hermann Einsele, Reinhard Vonthein, Claus Claussen, Marius Horger.   

Abstract

OBJECTIVE: The aim of this study was to assess CT signs of invasive pulmonary aspergillosis (IPA) and their long-term kinetics in correlation with clinical findings and outcome.
MATERIALS AND METHODS: Three hundred ten serial CT scans (mean, 7.7) in 40 consecutive patients were reviewed retrospectively over a median follow-up of 112 days (range, 5-841 days). Along with underlying disease, hematopoietic stem cell transplantation, neutropenia, graft-versus-host disease or antifungal treatment, signs of IPA, and number or size of lesions were evaluated regarding outcome and radiologic dynamics.
RESULTS: On the day of IPA diagnosis, median lesion number and size were 3 or 3.1 cm(2), respectively. Irrespective of antifungal therapy, 90% of patients showed an increase in lesion size and number until day 9 (median and mean). Lesion size subsequently showed a median plateau phase of 3.5 days (mean, 7), during which median lesion numbers dropped by 17%. Consequently, 42.5% of patients showed a complete radiologic remission within a median 80 days. Of all parameters, formation of cavitation most strongly predicted time until radiologic remission, which was 2.5 times as long in patients with cavitary lesions. Likewise, cavitations were strong precursors of beneficial outcome (odds ratio, 8.4; confidence interval [CI], 1.07-176).
CONCLUSION: The kinetics of radiologic signs of IPA adheres to a distinctive pattern with initial rise in number and size, followed by a plateau phase of size and gradual reduction. Both time until complete radiologic remission and outcome are independent of initial or maximum lesion size and number yet strongly influenced by cavitation.

Entities:  

Mesh:

Year:  2006        PMID: 16861545     DOI: 10.2214/AJR.05.0513

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases.

Authors:  J Qin; Y Fang; Y Dong; K Zhu; B Wu; Y An; H Shan
Journal:  Br J Radiol       Date:  2012-04-11       Impact factor: 3.039

2.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patients.

Authors:  Georg Maschmeyer
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

3.  Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography.

Authors:  Yoshie Kunihiro; Nobuyuki Tanaka; Reo Kawano; Toshiaki Yujiri; Makoto Kubo; Kazuhiro Ueda; Toshikazu Gondo; Taiga Kobayashi; Tsuneo Matsumoto
Journal:  Eur Radiol       Date:  2019-05-06       Impact factor: 5.315

4.  Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis.

Authors:  J J Vehreschild; C P Heussel; A H Groll; M J G T Vehreschild; G Silling; G Würthwein; M Brecht; O A Cornely
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

5.  Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings.

Authors:  Bo Da Nam; Tae Jung Kim; Kyung Soo Lee; Tae Sung Kim; Joungho Han; Myung Jin Chung
Journal:  Eur Radiol       Date:  2017-08-10       Impact factor: 5.315

6.  High-resolution CT findings of pulmonary infections after orthotopic liver transplantation in 453 patients.

Authors:  J Qin; J Xu; Y Dong; W Tang; B Wu; Y An; H Shan
Journal:  Br J Radiol       Date:  2012-09-19       Impact factor: 3.039

Review 7.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

Review 8.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

9.  How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors:  Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

10.  Invasive aspergillosis due to Neosartorya udagawae.

Authors:  Donald C Vinh; Yvonne R Shea; Janyce A Sugui; Edgardo R Parrilla-Castellar; Alexandra F Freeman; J William Campbell; Stefania Pittaluga; Pamela A Jones; Adrian Zelazny; David Kleiner; Kyung J Kwon-Chung; Steven M Holland
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.